Veeva Systems Inc
NYSE:VEEV

Watchlist Manager
Veeva Systems Inc Logo
Veeva Systems Inc
NYSE:VEEV
Watchlist
Price: 224.89 USD 0.33% Market Closed
Market Cap: 36.4B USD
Have any thoughts about
Veeva Systems Inc?
Write Note

Veeva Systems Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Veeva Systems Inc
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Veeva Systems Inc
NYSE:VEEV
Total Current Liabilities
$857m
CAGR 3-Years
17%
CAGR 5-Years
23%
CAGR 10-Years
23%
Inspire Medical Systems Inc
NYSE:INSP
Total Current Liabilities
$74.3m
CAGR 3-Years
30%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Total Current Liabilities
$147.3m
CAGR 3-Years
13%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Total Current Liabilities
$961.5m
CAGR 3-Years
42%
CAGR 5-Years
33%
CAGR 10-Years
24%
Certara Inc
NASDAQ:CERT
Total Current Liabilities
$130m
CAGR 3-Years
20%
CAGR 5-Years
15%
CAGR 10-Years
N/A
W
Waystar Holding Corp
NASDAQ:WAY
Total Current Liabilities
$123.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Veeva Systems Inc
Glance View

Market Cap
36.5B USD
Industry
Health Care
Economic Moat
Narrow

Veeva Systems Inc., born in the heart of Silicon Valley in 2007, embarked on its journey with a clear mission: to revolutionize the pharmaceutical and life sciences industries with cloud-based solutions. Founded by Peter Gassner, who previously held leadership roles at Salesforce and PeopleSoft, Veeva identified a niche opportunity amid the highly-regulated, complex landscape of healthcare. The company began by offering Customer Relationship Management (CRM) software tailored for the life sciences sector, allowing clients to stay compliant with industry regulations while efficiently managing relationships across the intricate healthcare network. Veeva’s CRM solutions gradually became instrumental for pharmaceutical and biotech companies in conducting their marketing, sales, and collaboration activities. As Veeva expanded, it diversified its portfolio by delving into other digital solutions, such as data management and analytics, content management, and regulatory and compliance software. Its Vault platform stood out, providing a unified suite for managing a vast array of business processes and content across powerful cloud applications. This approach enabled Veeva to serve its clientele throughout the drug development lifecycle, from research and development to commercialization. By adopting a subscription-based pricing model, Veeva ensured a steady revenue stream while continuously enhancing its offerings, solidifying its position as both a trusted partner and a critical component of its clients’ operational infrastructure. Through these strategic expansions, Veeva Systems Inc. not only adapted to the evolving demands of the healthcare sector but also reinforced its dominance in the specialized domain of life sciences cloud technology.

VEEV Intrinsic Value
127.08 USD
Overvaluation 43%
Intrinsic Value
Price

See Also

What is Veeva Systems Inc's Total Current Liabilities?
Total Current Liabilities
857m USD

Based on the financial report for Oct 31, 2024, Veeva Systems Inc's Total Current Liabilities amounts to 857m USD.

What is Veeva Systems Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
23%

Over the last year, the Total Current Liabilities growth was 12%. The average annual Total Current Liabilities growth rates for Veeva Systems Inc have been 17% over the past three years , 23% over the past five years , and 23% over the past ten years .

Back to Top